Celebrating the discovery of mutated CALR
What is
essential
thrombocythemia
(ET)?
Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.
Learn more about ETWhat is
polycythemia vera
(PV)?
The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.
Learn more about PVWhat is
myelofibrosis
(MF)?
MF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.
Learn more about MFEvery patient experience is unique and provides new clues for researchers and clinicians.
In our 24-year history, MPNRF has contributed to some of the most influential MPN research discoveries.
Engage with us to ensure that new therapies have the maximum impact on patient outcomes and quality of life.
Download our Voice of the Patient report
Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.
Your investment supports doctors and researchers around the world who are dedicated to finding cures for MPNs.
MPN NEWS | January 27, 2025
Trouble in the neighborhood: How one type of chromosome abnormality is more common than previously thought A recent study by Dr. Vesna Najfeld and her team brings fresh insights into myelofibrosis (MF), a type of myeloproliferative neoplasm (MPN). Their work highlights the importance of closely tracking genetic changes over time and suggests that changes around… Read More »Trouble in the neighborhood: How one type of chromosome abnormality is more common than previously thought
A wedding with a cause: How Adam and Jenny transformed tradition into purpose
MPN NEWS | January 27, 2025
A wedding with a cause: How Adam and Jenny transformed tradition into purpose When Jenny Applequist was diagnosed with a myeloproliferative neoplasm (MPN) in 2019, it marked the beginning of a transformative journey. “I felt a flood of emotions when I was first diagnosed,” Jenny shared. “I was still in denial for years.” Over time,… Read More »A wedding with a cause: How Adam and Jenny transformed tradition into purpose
Dr. Anandi Krishnan, PhD Research Profile
MPN NEWS | January 27, 2025
Profile: Dr. Anandi Krishnan, PhDRutgers University Dr. Anandi Krishnan: A pioneer in collaborative MPN research Dr. Anandi Krishnan, PhD, believes that meaningful scientific breakthroughs don’t happen in isolation. In an academic world where scientific discovery often feels siloed, Dr. Anandi Krishnan’s new laboratory in the department of biomedical engineering at Rutgers University operates like a bustling… Read More »Dr. Anandi Krishnan, PhD Research Profile
Join our community to get the latest research, patient stories, and exclusive content delivered right to your inbox. Plus, when you subscribe, receive the latest NCCN guidelines and resources to support your journey.
JOIN OVER 20,000 SUBSCRIBERS. UNSUBSCRIBE ANYTIME.